Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enlivex Therapeutics Ltd (NQ: ENLV ) 1.450 -0.010 (-0.68%) Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 66,697 Open 1.430 Bid (Size) 1.350 (3) Ask (Size) 1.530 (2) Prev. Close 1.460 Today's Range 1.370 - 1.520 52wk Range 1.150 - 4.590 Shares Outstanding 18,306,186 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 29, 2024 Via Benzinga Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events April 29, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire Performance YTD -56.06% -56.06% 1 Month +11.54% +11.54% 3 Month -49.48% -49.48% 6 Month -17.14% -17.14% 1 Year -48.40% -48.40% More News Read More Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis April 22, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis April 16, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire Tesla To $180? Here Are 10 Top Analyst Forecasts For Friday April 12, 2024 Via Benzinga Nasdaq Jumps 250 Points; Crude Oil Down 1% April 11, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis April 11, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Via Benzinga Dow Dips 100 Points; CarMax Earnings Miss Views April 11, 2024 Via Benzinga Topics Earnings Stocks Exposures Financial US Equities Nasdaq Gains Over 50 Points; US Producer Prices Increase In March April 11, 2024 Via Benzinga Topics Stocks Exposures US Equities Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis April 11, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023 April 05, 2024 Via InvestorPlace Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV March 22, 2024 Via ACCESSWIRE Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis February 26, 2024 Via ACCESSWIRE Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals February 21, 2024 Via ACCESSWIRE Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method February 07, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis January 17, 2024 From Enlivex Therapeutics Ltd Via GlobeNewswire Enlivex Therapeutics Ltd. (NASDAQ: ENLV) Leading the Way in Tuesday Trading Based on Percentage Gain January 02, 2024 Via Investor Brand Network Exposures COVID-19 Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 26, 2023 Via Benzinga Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis December 20, 2023 From Enlivex Therapeutics Ltd Via GlobeNewswire Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Via Benzinga MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer November 21, 2023 From MediWound Ltd. Via GlobeNewswire Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 03, 2023 Via Benzinga Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results September 11, 2023 From Enlivex Therapeutics Ltd Via GlobeNewswire Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 07, 2023 From Enlivex Therapeutics Ltd Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.